Wells Fargo’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $157K | Buy |
26,646
+591
| +2% | +$3.48K | ﹤0.01% | 4519 |
|
2025
Q1 | $219K | Buy |
26,055
+1,259
| +5% | +$10.6K | ﹤0.01% | 4204 |
|
2024
Q4 | $184K | Buy |
24,796
+7,769
| +46% | +$57.8K | ﹤0.01% | 4359 |
|
2024
Q3 | $98.8K | Sell |
17,027
-2,188
| -11% | -$12.7K | ﹤0.01% | 4635 |
|
2024
Q2 | $128K | Buy |
19,215
+3,591
| +23% | +$23.9K | ﹤0.01% | 4439 |
|
2024
Q1 | $204K | Buy |
15,624
+2,959
| +23% | +$38.6K | ﹤0.01% | 4100 |
|
2023
Q4 | $161K | Buy |
12,665
+2,119
| +20% | +$27K | ﹤0.01% | 4216 |
|
2023
Q3 | $138K | Sell |
10,546
-10,545
| -50% | -$138K | ﹤0.01% | 4261 |
|
2023
Q2 | $540K | Buy |
21,091
+11,011
| +109% | +$282K | ﹤0.01% | 3691 |
|
2023
Q1 | $254K | Buy |
10,080
+9,022
| +853% | +$227K | ﹤0.01% | 4040 |
|
2022
Q4 | $24.3K | Sell |
1,058
-16,107
| -94% | -$370K | ﹤0.01% | 4866 |
|
2022
Q3 | $379K | Buy |
17,165
+16,195
| +1,670% | +$358K | ﹤0.01% | 3617 |
|
2022
Q2 | $14K | Sell |
970
-27,145
| -97% | -$392K | ﹤0.01% | 5328 |
|
2022
Q1 | $531K | Sell |
28,115
-6,523
| -19% | -$123K | ﹤0.01% | 4094 |
|
2021
Q4 | $646K | Sell |
34,638
-78,689
| -69% | -$1.47M | ﹤0.01% | 4177 |
|
2021
Q3 | $3.05M | Buy |
113,327
+39,814
| +54% | +$1.07M | ﹤0.01% | 3143 |
|
2021
Q2 | $2.3M | Buy |
+73,513
| New | +$2.3M | ﹤0.01% | 3397 |
|